Home/Filings/4/0000914190-12-000240
4//SEC Filing

BREWER RICHARD B 4

Accession 0000914190-12-000240

CIK 0001133869other

Filed

Apr 1, 8:00 PM ET

Accepted

Apr 2, 3:21 PM ET

Size

10.2 KB

Accession

0000914190-12-000240

Insider Transaction Report

Form 4
Period: 2012-03-30
BREWER RICHARD B
DirectorExecutive Chairman
Transactions
  • Purchase

    Common Stock

    2012-03-30+125,000125,000 total
  • Purchase

    Warrant (Right to Buy)

    2012-03-30+93,75093,750 total
    Exercise: $0.50Common Stock (93,750 underlying)
Holdings
  • Stock Option (Right to Buy)

    Exercise: $0.37Exp: 2020-07-26Common Stock (900,000 underlying)
    900,000
  • Stock Option (Right to Buy)

    Exercise: $0.32From: 2010-07-21Exp: 2020-07-21Common Stock (450,000 underlying)
    450,000
Footnotes (3)
  • [F1]The reported securities were purchased by the Reporting Person at an aggregate price of $0.40 for one share of common stock and three-fourths of a warrant to purchase one share of common stock.
  • [F2]This option vests in eight equal quarterly installments beginning 9/30/2011.
  • [F3]The warrants are exercisable for a period of five years beginning on the earlier of (i) the date on which a registration statement under the Securities Act of 1933, as amended, covering the shares of common stock issuable upon exercise of the warrants and the subsequent resale of such shares is declared effective by the Securities and Exchange Commission, and (ii) one year and one day after issuance.

Issuer

Nile Therapeutics, Inc.

CIK 0001133869

Entity typeother

Related Parties

1
  • filerCIK 0001189164

Filing Metadata

Form type
4
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 3:21 PM ET
Size
10.2 KB